4.19
+0.03(+0.72%)
Currency In USD
Previous Close | 4.16 |
Open | 4.09 |
Day High | 4.24 |
Day Low | 3.99 |
52-Week High | 29.3 |
52-Week Low | 3.81 |
Volume | 2M |
Average Volume | 1.95M |
Market Cap | 386.22M |
PE | -3.74 |
EPS | -1.12 |
Moving Average 50 Days | 6.82 |
Moving Average 200 Days | 15.5 |
Change | 0.03 |
If you invested $1000 in Myriad Genetics, Inc. (MYGN) 10 years ago, it would be worth $127.12 as of June 01, 2025 at a share price of $4.19. Whereas If you bought $1000 worth of Myriad Genetics, Inc. (MYGN) shares 5 years ago, it would be worth $275.84 as of June 01, 2025 at a share price of $4.19.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
GlobeNewswire Inc.
May 27, 2025 8:05 PM GMT
Two Molecular Residual Disease (MRD) studies highlighting clinical data among seven new studies to be shared by Myriad and collaboratorsSALT LAKE CITY, May 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular dia
Updated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences
GlobeNewswire Inc.
May 14, 2025 8:45 PM GMT
Correction: Time of BofA ConferenceSALT LAKE CITY, May 14, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that management plans to participate in the f
Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology
GlobeNewswire Inc.
May 07, 2025 8:30 PM GMT
Study suggests that utilizing RiskScore drives breast cancer screening tailored to individual riskSALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicin